Systemic and lung tissue upregulation of these IFN-γ–induced cytokines in COVID-19 has been noted in many studies, and this axis has already been proposed by others as a therapeutic target for COVID-19 and other serious diseases, including cancer (6, 10, 15, 18, 26, 38, 45). Here, IFNG is linked to COVID-19.